Skip to main content
SpringerLink
Log in

Komplementäre und ergänzende Verfahren in der Kopfschmerztherapie

Complementary and supplementary procedures in the treatment of headache

  • Schwerpunkt
  • Published:
Der Schmerz Aims and scope Submit manuscript

Zusammenfassung

In Deutschland gehören Kopfschmerzen zu den Erkrankungen, die am häufigsten zu gesundheitlichen Einschränkungen und zum Arztbesuch führen. Auch bei Kindern sind Kopfschmerzen häufig mit Alltagseinschränkungen verbunden. Trotzdem steht der Versorgungsgrad für Kopfschmerzerkrankungen in keinem Verhältnis zum medizinischen Bedarf. Auch deshalb werden von Patienten regelmäßig komplementäre und unterstützende Therapieverfahren genutzt. Die vorliegende Übersicht zeigt für primäre Kopfschmerzen im Kindes- und Erwachsenenalter aktuell genutzte Verfahren, deren methodischen Ansatz und vorhandene wissenschaftliche Evidenz. Auch wird die Sicherheit der Therapiemöglichkeiten eingeordnet. Zu den Verfahren zählen Physiotherapie, Neuraltherapie, Akupunktur, Homöopathie, Phytotherapie und die Einnahme von Nahrungsergänzungsmitteln. Für Kinder und Jugendliche mit Kopfschmerzen gibt es im Bereich der Nahrungsergänzungsmittel für Coenzym Q10, Riboflavin, Magnesium und Vitamin D Untersuchungen, die auf spezifische Effekte in der Kopfschmerzreduktion hinweisen.

Abstract

In Germany, headache is one of the illnesses that most frequently leads to health impairments and to consultation with physicians. Even in children, headache is often associated with restricted activities of daily life. Nevertheless, the level of care for headache disorders is disproportionate to the medical needs. As a result, patients regularly use complementary and supportive therapeutic procedures. This review shows the procedures currently used for primary headache in childhood and adulthood, the methodological approaches and existing scientific evidence. The safety of the therapeutic options is also classified. These methods include physiotherapy, neural therapy, acupuncture, homeopathy, phytotherapy and the intake of dietary supplements. For children and adolescents with headaches, there are studies in the field of dietary supplements for coenzyme Q10, riboflavin, magnesium and vitamin D, which indicate specific effects in the reduction of headaches.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Ng JY, Hanna C (2021) Headache and migraine clinical practice guidelines: a systematic review and assessment of complementary and alternative medicine recommendations. BMC Complement Med Ther 21(1):236. https://doi.org/10.1186/s12906-021-03401-3

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL (1993) Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med 328(4):246–252. https://doi.org/10.1056/NEJM199301283280406

    Article  CAS  PubMed  Google Scholar 

  3. Kropp P, Meyer B, Dresler T, Fritsche G, Gaul C, Niederberger U, Förderreuther S, Malzacher V, Jürgens TP, Marziniak M, Straube A (2017) Entspannungsverfahren und verhaltenstherapeutische Interventionen zur Behandlung der Migräne : Leitlinie der Deutschen Migräne- und Kopfschmerzgesellschaft. Schmerz 31(5):433–447. https://doi.org/10.1007/s00482-017-0214-1

    Article  CAS  PubMed  Google Scholar 

  4. Cameron C, Kelly S, Hsieh SC, Murphy M, Chen L, Kotb A, Peterson J, Coyle D, Skidmore B, Gomes T, Clifford T, Wells G (2015) Triptans in the acute treatment of migraine: a systematic review and network meta-analysis. Headache 55(4):221–235. https://doi.org/10.1111/head.12601

    Article  PubMed  Google Scholar 

  5. Diener H‑C, Förderreuther S, Kropp P et al (2022) Therapie der Migräneattacke und Prophylaxe der Migräne, S1-Leitlinie. Deutsche Gesellschaft für Neurologie

    Google Scholar 

  6. Gaul C, Eismann R, Schmidt T, May A, Leinisch E, Wieser T, Evers S, Henkel K, Franz G, Zierz S (2009) Use of complementary and alternative medicine in patients suffering from primary headache disorders. Cephalalgia 29(10):1069–1078. https://doi.org/10.1111/j.1468-2982.2009.01841.x

    Article  CAS  PubMed  Google Scholar 

  7. Hsu YY, Chen CJ, Wu SH, Chen KH (2022) Cold intervention for relieving migraine symptoms: a systematic review and meta-analysis. J Clin Nurs. https://doi.org/10.1111/jocn.16368

    Article  PubMed  Google Scholar 

  8. Luedtke K, Allers A, Schulte LH, May A (2016) Efficacy of interventions used by physiotherapists for patients with headache and migraine-systematic review and meta-analysis. Cephalalgia 36(5):474–492. https://doi.org/10.1177/0333102415597889 (Erratum in: Cephalalgia. 2016 Jul;36(8):819–20)

    Article  PubMed  Google Scholar 

  9. Falsiroli Maistrello L, Rafanelli M, Turolla A (2019) Manual therapy and quality of life in people with headache: systematic review and meta-analysis of randomized controlled trials. Curr Pain Headache Rep 23(10):78. https://doi.org/10.1007/s11916-019-0815-8

    Article  PubMed  Google Scholar 

  10. Jung A, Eschke RC, Struss J, Taucher W, Luedtke K (2022) Effectiveness of physiotherapy interventions on headache intensity, frequency, duration and quality of life of patients with tension-type headache. A systematic review and network meta-analysis. Cephalalgia 42(9):944–965. https://doi.org/10.1177/03331024221082073

    Article  PubMed  Google Scholar 

  11. Al-Khazali HM, Younis S, Al-Sayegh Z, Ashina S, Ashina M, Schytz HW (2022) Prevalence of neck pain in migraine: a systematic review and meta-analysis. Cephalalgia 42(7):663–673. https://doi.org/10.1177/03331024211068073

    Article  PubMed  Google Scholar 

  12. Bartsch T, Goadsby PJ (2005) Anatomy and physiology of pain referral patterns in primary and cervicogenic headache disorders. Headache Curr 2(2):42–48

    Article  Google Scholar 

  13. Herranz-Gómez A, García-Pascual I, Montero-Iniesta P, Touche RL, Paris-Alemany A (2021) Effectiveness of exercise and manual therapy as treatment for patients with migraine, tension-type headache or cervicogenic headache: an umbrella and mapping review with meta-meta-analysis. Appl Sci 11(15):6856

    Article  Google Scholar 

  14. Kelman L (2007) The triggers or precipitants of the acute migraine attack. Cephalalgia 27(5):394–402. https://doi.org/10.1111/j.1468-2982.2007.01303.x

    Article  CAS  PubMed  Google Scholar 

  15. Gazerani P (2021) A bidirectional view of migraine and diet relationship. Neuropsychiatr Dis Treat 17:435–451. https://doi.org/10.2147/NDT.S282565

    Article  PubMed  PubMed Central  Google Scholar 

  16. Straube A, Ruscheweyh R (2020) Migräne und der Gastrointestinaltrakt – Eine wechselseitige Beziehung. Nervenheilkunde 39:26–30

    Article  Google Scholar 

  17. Di Vincenzo A, Beghetto M, Vettor R, Tana C, Rossato M, Bond DS, Pagano C (2020) Effects of surgical and non-surgical weight loss on migraine headache: a systematic review and meta-analysis. Obes Surg 30(6):2173–2185. https://doi.org/10.1007/s11695-020-04429-z

    Article  PubMed  Google Scholar 

  18. Dang JT, Lee JKH, Kung JY, Switzer NJ, Karmali S, Birch DW (2020) The effect of bariatric surgery on migraines: a systematic review and meta-analysis. Obes Surg 30(3):1061–1067. https://doi.org/10.1007/s11695-019-04290-9

    Article  PubMed  Google Scholar 

  19. Straube A, Müller H, Stiegelbauer V, Frauwallner A (2018) Migraine prophylaxis with a probiotic. Results of an uncontrolled observational study with 1,020 patients. MMW Fortschr Med 160(5):16–21

    Article  PubMed  Google Scholar 

  20. de Roos NM, van Hemert S, Rovers JMP, Smits MG, Witteman BJM (2017) The effects of a multispecies probiotic on migraine and markers of intestinal permeability-results of a randomized placebo-controlled study. Eur J Clin Nutr 71(12):1455–1462. https://doi.org/10.1038/ejcn.2017.57

    Article  CAS  PubMed  Google Scholar 

  21. Alpay K, Ertas M, Orhan EK, Ustay DK, Lieners C, Baykan B (2010) Diet restriction in migraine, based on IgG against foods: a clinical double-blind, randomised, cross-over trial. Cephalalgia 30(7):829–837. https://doi.org/10.1177/0333102410361404

    Article  PubMed  PubMed Central  Google Scholar 

  22. Lelleck VV, Schulz F, Witt O, Kühn G, Klein D, Gendolla A, Evers S, Gaul C, Thaçi D, Sina C, Schröder T (2022) A digital therapeutic allowing a personalized low-glycemic nutrition for the prophylaxis of migraine: real world data from two prospective studies. Nutrients 14(14):2927. https://doi.org/10.3390/nu14142927

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Putananickal N, Gross EC, Orsini AL, Schmidt S, Hafner P, Gocheva V, Nagy S, Henzi BC, Rubino D, Vogt DR, Cichon S, Sandor P, Fischer D (2022) Efficacy and safety of exogenous beta-hydroxybutyrate for preventive treatment in episodic migraine: a single-centred, randomised, placebo-controlled, double-blind crossover trial. Cephalalgia 42(4):302–311. https://doi.org/10.1177/03331024211043792

    Article  PubMed  Google Scholar 

  24. Gross EC, Putananickal N, Orsini AL, Schoenen J, Fischer D, Soto-Mota A (2023) Defining metabolic migraine with a distinct subgroup of patients with suboptimal inflammatory and metabolic markers. Sci Rep 13(1):3787. https://doi.org/10.1038/s41598-023-28499-y

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Barop H (2015) Lehrbuch und Atlas der Neuraltherapie nach Huneke, 2. Aufl. Haug, Stuttgart

    Google Scholar 

  26. Robbins MS, Kuruvilla D, Blumenfeld A, Charleston L 4th, Sorrell M, Robertson CE, Grosberg BM, Bender SD, Napchan U, Ashkenazi A, Peripheral Nerve Blocks and Other Interventional Procedures Special Interest Section of the American Headache Society (2014) Trigger point injections for headache disorders: expert consensus methodology and narrative review. Headache 54(9):1441–1459. https://doi.org/10.1111/head.12442

    Article  PubMed  Google Scholar 

  27. Song Y, Li T, Ma C, Liu H, Liang F, Yang Y (2022) Comparative efficacy of acupuncture-related therapy for migraine: a systematic review and network meta-analysis. Front Neurol 13:1010410. https://doi.org/10.3389/fneur.2022.1010410

    Article  PubMed  PubMed Central  Google Scholar 

  28. Linde K, Allais G, Brinkhaus B, Fei Y, Mehring M, Vertosick EA, Vickers A, White AR (2016) Acupuncture for the prevention of episodic migraine. Cochrane Database Syst Rev 2016(6):CD1218. https://doi.org/10.1002/14651858.CD001218.pub3

    Article  PubMed  PubMed Central  Google Scholar 

  29. Linde K, Allais G, Brinkhaus B, Fei Y, Mehring M, Shin BC, Vickers A, White AR (2016) Acupuncture for the prevention of tension-type headache. Cochrane Database Syst Rev 4(4):CD7587. https://doi.org/10.1002/14651858.CD007587.pub2

    Article  PubMed  Google Scholar 

  30. Endres HG, Böwing G, Diener HC, Lange S, Maier C, Molsberger A, Zenz M, Vickers AJ, Tegenthoff M (2007) Acupuncture for tension-type headache: a multicentre, sham-controlled, patient-and observer-blinded, randomised trial. J Headache Pain 8(5):306–314. https://doi.org/10.1007/s10194-007-0416-5

    Article  PubMed  PubMed Central  Google Scholar 

  31. Diener HC, Kronfeld K, Boewing G, Lungenhausen M, Maier C, Molsberger A, Tegenthoff M, Trampisch HJ, Zenz M, Meinert R, GERAC Migraine Study Group (2006) Efficacy of acupuncture for the prophylaxis of migraine: a multicentre randomised controlled clinical trial. Lancet Neurol 5(4):310–316. https://doi.org/10.1016/S1474-4422(06)70382-9 (Erratum in: Lancet Neurol. 2008 Jun;7(6):475)

    Article  PubMed  Google Scholar 

  32. Headache Classification Committee of the International Headache Society (IHS) (2018) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38(1):1–211

  33. Gaul C (2012) Kopfschmerzen: Welches Potenzial hat Phytotherapie? Allgemeinarzt 34:46–48

    Google Scholar 

  34. Göbel H, Schmidt G, Soyka D (1994) Effect of peppermint and eucalyptus oil preparations on neurophysiological and experimental algesimetric headache parameters. Cephalalgia 14(3):228–234. https://doi.org/10.1046/j.1468-2982.1994.014003228.x (discussion 182)

    Article  PubMed  Google Scholar 

  35. Göbel H, Fresenius J, Heinze A, Dworschak M, Soyka D (1996) Effektivität von Oleum menthae piperitae und von Paracetamol in der Therapie des Kopfschmerzes vom Spannungstyp. Nervenarzt 67(8):672–681. https://doi.org/10.1007/s001150050040

    Article  PubMed  Google Scholar 

  36. Borhani Haghighi A, Motazedian S, Rezaii R, Mohammadi F, Salarian L, Pourmokhtari M, Khodaei S, Vossoughi M, Miri R (2010) Cutaneous application of menthol 10 % solution as an abortive treatment of migraine without aura: a randomised, double-blind, placebo-controlled, crossed-over study. Int J Clin Pract 64(4):451–456. https://doi.org/10.1111/j.1742-1241.2009.02215.x

    Article  CAS  PubMed  Google Scholar 

  37. Gossrau G, Frost M, Klimova A, Koch T, Sabatowski R, Mignot C, Haehner A (2022) Interictal osmophobia is associated with longer migraine disease duration. J Headache Pain 23(1):81. https://doi.org/10.1186/s10194-022-01451-7

    Article  PubMed  PubMed Central  Google Scholar 

  38. Lampl C, Haider B, Schweiger C (2012) Long-term efficacy of Boswellia serrata in four patients with chronic cluster headache. Cephalalgia 32(9):719–722. https://doi.org/10.1177/0333102412451357

    Article  PubMed  Google Scholar 

  39. Gaul C, Diener HC, Danesch U, Migravent® Study Group (2015) Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial. J Headache Pain 16:516. https://doi.org/10.1186/s10194-015-0516-6

    Article  CAS  PubMed  Google Scholar 

  40. Togha M, Razeghi Jahromi S, Ghorbani Z, Martami F, Seifishahpar M (2018) Serum vitamin D status in a group of migraine patients compared with healthy controls: a case-control study. Headache 58(10):1530–1540. https://doi.org/10.1111/head.13423

    Article  PubMed  Google Scholar 

  41. Rapisarda L, Mazza MR, Tosto F, Gambardella A, Bono F, Sarica A (2018) Relationship between severity of migraine and vitamin D deficiency: a case-control study. Neurol Sci 39(1):167–168. https://doi.org/10.1007/s10072-018-3384-4

    Article  PubMed  Google Scholar 

  42. Mottaghi T, Khorvash F, Askari G, Maracy MR, Ghiasvand R, Maghsoudi Z, Iraj B (2013) The relationship between serum levels of vitamin D and migraine. J Res Med Sci 18(1):S66–70

    PubMed  PubMed Central  Google Scholar 

  43. Ghorbani Z, Togha M, Rafiee P, Ahmadi ZS, Rasekh Magham R, Djalali M, Shahemi S, Martami F, Zareei M, Razeghi Jahromi S, Ariyanfar S, Mahmoudi M (2020) Vitamin D3 might improve headache characteristics and protect against inflammation in migraine: a randomized clinical trial. Neurol Sci 41(5):1183–1192. https://doi.org/10.1007/s10072-019-04220-8

    Article  PubMed  Google Scholar 

  44. Gazerani P, Fuglsang R, Pedersen JG, Sørensen J, Kjeldsen JL, Yassin H, Nedergaard BS (2019) A randomized, double-blinded, placebo-controlled, parallel trial of vitamin D3 supplementation in adult patients with migraine. Curr Med Res Opin 35(4):715–723. https://doi.org/10.1080/03007995.2018.1519503

    Article  CAS  PubMed  Google Scholar 

  45. Mottaghi T, Askari G, Khorvash F, Maracy MR (2015) Effect of Vitamin D supplementation on symptoms and C‑reactive protein in migraine patients. J Res Med Sci 20(5):477–482. https://doi.org/10.4103/1735-1995.163971

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Pradalier A, Bakouche P, Baudesson G, Delage A, Cornaille-Lafage G, Launay JM, Biason P (2001) Failure of omega‑3 polyunsaturated fatty acids in prevention of migraine: a double-blind study versus placebo. Cephalalgia 21(8):818–822. https://doi.org/10.1046/j.1468-2982.2001.218240.x

    Article  CAS  PubMed  Google Scholar 

  47. Tajmirriahi M, Sohelipour M, Basiri K, Shaygannejad V, Ghorbani A, Saadatnia M (2012) The effects of sodium valproate with fish oil supplementation or alone in migraine prevention: a randomized single-blind clinical trial. Iran J Neurol 11(1):21–24

    PubMed  PubMed Central  Google Scholar 

  48. Powers SW, Coffey CS, Chamberlin LA, Ecklund DJ, Klingner EA, Yankey JW, Korbee LL, Porter LL, Hershey AD, CHAMP Investigators (2017) Trial of amitriptyline, topiramate, and placebo for pediatric migraine. N Engl J Med 376(2):115–124. https://doi.org/10.1056/NEJMoa1610384

    Article  CAS  PubMed  Google Scholar 

  49. Oskoui M, Pringsheim T, Billinghurst L, Potrebic S, Gersz EM, Gloss D, Holler-Managan Y, Leininger E, Licking N, Mack K, Powers SW, Sowell M, Victorio MC, Yonker M, Zanitsch H, Hershey AD (2019) Practice guideline update summary: pharmacologic treatment for pediatric migraine prevention: report of the guideline development, dissemination, and implementation subcommittee of the American academy of neurology and the American headache society. Headache 59(8):1144–1157. https://doi.org/10.1111/head.13625

    Article  PubMed  Google Scholar 

  50. Dalla Libera D, Colombo B, Pavan G, Comi G (2014) Complementary and alternative medicine (CAM) use in an Italian cohort of pediatric headache patients: the tip of the iceberg. Neurol Sci 35(1):145–148. https://doi.org/10.1007/s10072-014-1756-y

    Article  PubMed  Google Scholar 

  51. Sobe H, Richter M, Berner R, von der Hagen M, Hähner A, Röder I, Koch T, Sabatowski R, Klimova A, Gossrau G (2022) Functional improvement in children and adolescents with primary headache after an interdisciplinary multimodal therapy program: the DreKiP study. J Headache Pain 23(1):109. https://doi.org/10.1186/s10194-022-01481-1

    Article  PubMed  PubMed Central  Google Scholar 

  52. Shulman J, Conroy C, Cybulski A, Smith KR, Jervis K, Johnson H, Zurakowski D, Sethna NF (2022) Does intensive interdisciplinary pain treatment improve pediatric headache-related disability? Disabil Rehabil 44(2):194–201. https://doi.org/10.1080/09638288.2020.1762125

    Article  PubMed  Google Scholar 

  53. Benore E, Webster EE, Wang L, Banez G (2018) Longitudinal analysis of patient-reported outcomes from an interdisciplinary pediatric pain rehabilitation program for children with chronic migraine and headache. Headache 58(10):1556–1567. https://doi.org/10.1111/head.13389

    Article  PubMed  Google Scholar 

  54. Taylor FR (2011) Nutraceuticals and headache: the biological basis. Headache 51(3):484–501. https://doi.org/10.1111/j.1526-4610.2011.01847.x

    Article  PubMed  Google Scholar 

  55. Bhurat R, Premkumar S, Manokaran RK (2022) Serum magnesium levels in children with and without migraine: a cross-sectional study. Indian Pediatr 59(8):623–625

    Article  PubMed  Google Scholar 

  56. Kovacevic G, Stevanovic D, Bogicevic D, Nikolic D, Ostojic S, Tadic BV, Nikolic B, Bosiocic I, Ivancevic N, Jovanovic K, Samardzic J, Jancic J (2017) A 6‑month follow-up of disability, quality of life, and depressive and anxiety symptoms in pediatric migraine with magnesium prophylaxis. Magnes Res 30(4):133–141. https://doi.org/10.1684/mrh.2018.0431

    Article  CAS  PubMed  Google Scholar 

  57. Edvinsson L (2022) Calcitonin gene-related peptide (CGRP) is a key molecule released in acute migraine attacks-successful translation of basic science to clinical practice. J Intern Med 292(4):575–586. https://doi.org/10.1111/joim.13506

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Yaghini O, Hoseini N, Ghazavi MR, Mansouri V, Nasiri J, Moosavian T, Salehi MM (2022) A comparative study on the efficacy of coenzyme Q10 and amitriptyline in the prophylactic treatment of migraine headaches in children: a randomized controlled trial. Adv Biomed Res 11:43. https://doi.org/10.4103/abr.abr_235_20

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Slater SK, Nelson TD, Kabbouche MA, LeCates SL, Horn P, Segers A, Manning P, Powers SW, Hershey AD (2011) A randomized, double-blinded, placebo-controlled, crossover, add-on study of CoEnzyme Q10 in the prevention of pediatric and adolescent migraine. Cephalalgia 31(8):897–905. https://doi.org/10.1177/0333102411406755

    Article  PubMed  Google Scholar 

  60. Athaillah A, Dimyati Y, Saing JH, Saing B, Hakimi H, Lelo A (2012) Riboflavin as migraine prophylaxis in adolescents. Paediatr Indones 52:132–137

    Article  Google Scholar 

  61. Namazi N, Heshmati J, Tarighat-Esfanjani A (2015) Supplementation with riboflavin (vitamin B2) for migraine prophylaxis in adults and children: a review. Int J Vitam Nutr Res 85(1):79–87. https://doi.org/10.1024/0300-9831/a000225

    Article  CAS  PubMed  Google Scholar 

  62. Talebian A, Soltani B, Banafshe HR, Moosavi GA, Talebian M, Soltani S (2018) Prophylactic effect of riboflavin on pediatric migraine: a randomized, double-blind, placebo-controlled trial. Electron physician 10(2):6279–6285. https://doi.org/10.19082/6279

    Article  PubMed  PubMed Central  Google Scholar 

  63. MacLennan SC, Wade FM, Forrest KM, Ratanayake PD, Fagan E, Antony J (2008) High-dose riboflavin for migraine prophylaxis in children: a double-blind, randomized, placebo-controlled trial. J Child Neurol 23(11):1300–1304. https://doi.org/10.1177/0883073808318053

    Article  PubMed  Google Scholar 

  64. Bruijn J, Duivenvoorden H, Passchier J, Locher H, Dijkstra N, Arts WF (2010) Medium-dose riboflavin as a prophylactic agent in children with migraine: a preliminary placebo-controlled, randomised, double-blind, cross-over trial. Cephalalgia 30(12):1426–1434. https://doi.org/10.1177/0333102410365106

    Article  PubMed  Google Scholar 

  65. Yamanaka G, Suzuki S, Takeshita M, Go S, Morishita N, Takamatsu T, Daida A, Morichi S, Ishida Y, Oana S, Nara S, Shimura M, Nishimata S, Kawashima H (2020) Effectiveness of low-dose riboflavin as a prophylactic agent in pediatric migraine. Brain Dev 42(7):523–528. https://doi.org/10.1016/j.braindev.2020.04.002

    Article  PubMed  Google Scholar 

  66. Das R, Qubty W (2021) Retrospective observational study on riboflavin prophylaxis in child and adolescent migraine. Pediatr Neurol 114:5–8. https://doi.org/10.1016/j.pediatrneurol.2020.09.009

    Article  PubMed  Google Scholar 

  67. Straube S, Andrew Moore R, Derry S, McQuay HJ (2009) Vitamin D and chronic pain. Pain 141(1):10–13. https://doi.org/10.1016/j.pain.2008.11.010

    Article  CAS  PubMed  Google Scholar 

  68. Fernandes de Abreu DA, Eyles D, Féron F (2009) Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology 34(1):S265–77. https://doi.org/10.1016/j.psyneuen.2009.05.023

    Article  CAS  PubMed  Google Scholar 

  69. Donmez A, Orun E, Sonmez FM (2018) Vitamin D status in children with headache: a case-control study. Clin Nutr ESPEN 23:222–227. https://doi.org/10.1016/j.clnesp.2017.09.010

    Article  CAS  PubMed  Google Scholar 

  70. Prakash S, Makwana P, Rathore C (2016) Vitamin D deficiency mimicking chronic tension-type headache in children. BMJ Case Rep 2016:bcr2015213833. https://doi.org/10.1136/bcr-2015-213833

    Article  PubMed  PubMed Central  Google Scholar 

  71. Dell’Isola GB, Tulli E, Sica R, Vinti V, Mencaroni E, Di Cara G, Striano P, Verrotti A (2021) The vitamin D role in preventing primary headache in adult and pediatric population. J Clin Med 10(24):5983. https://doi.org/10.3390/jcm10245983

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Cayir A, Turan MI, Tan H (2014) Effect of vitamin D therapy in addition to amitriptyline on migraine attacks in pediatric patients. Braz J Med Biol Res 47(4):349–354. https://doi.org/10.1590/1414-431x20143606

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Fallah R, Sarraf Yazd S, Sohrevardi SM (2020) Efficacy of topiramate alone and topiramate plus vitamin D3 in the prophylaxis of pediatric migraine: a randomized clinical trial. Iran J Child Neurol 14(4):77–86

    PubMed  PubMed Central  Google Scholar 

  74. Peres MF (2005) Melatonin, the pineal gland and their implications for headache disorders. Cephalalgia 25(6):403–411. https://doi.org/10.1111/j.1468-2982.2005.00889.x

    Article  CAS  PubMed  Google Scholar 

  75. Fallah R, Shoroki FF, Ferdosian F (2015) Safety and efficacy of melatonin in pediatric migraine prophylaxis. Curr Drug Saf 10(2):132–135. https://doi.org/10.2174/1574886309666140605114614

    Article  CAS  PubMed  Google Scholar 

  76. Miano S, Parisi P, Pelliccia A, Luchetti A, Paolino MC, Villa MP (2008) Melatonin to prevent migraine or tension-type headache in children. Neurol Sci 29(4):285–287. https://doi.org/10.1007/s10072-008-0983-5

    Article  PubMed  Google Scholar 

  77. Fallah R, Fazelishoroki F, Sekhavat L (2018) A randomized clinical trial comparing the efficacy of melatonin and amitriptyline in migraine prophylaxis of children. Iran J Child Neurol 12(1):47–54

    PubMed  PubMed Central  Google Scholar 

  78. Gelfand AA, Qubty W, Patniyot I, Grimes B, Pletcher MJ, Goadsby PJ, Cummings SR (2017) Home-based trials in adolescent migraine: a randomized clinical trial. JAMA Neurol 74(6):744–745. https://doi.org/10.1001/jamaneurol.2017.0285

    Article  PubMed  PubMed Central  Google Scholar 

  79. Orr SL, Venkateswaran S (2014) Nutraceuticals in the prophylaxis of pediatric migraine: evidence-based review and recommendations. Cephalalgia 34(8):568–583. https://doi.org/10.1177/0333102413519512

    Article  PubMed  Google Scholar 

  80. Moscano F, Guiducci M, Maltoni L, Striano P, Ledda MG, Zoroddu F, Raucci U, Villa MP, Parisi P (2019) An observational study of fixed-dose tanacetum parthenium nutraceutical preparation for prophylaxis of pediatric headache. Ital J Pediatr 45(1):36. https://doi.org/10.1186/s13052-019-0624-z

    Article  PubMed  PubMed Central  Google Scholar 

  81. Tsai SL, Reynoso E, Shin DW, Tsung JW (2021) Acupuncture as a nonpharmacologic treatment for pain in a pediatric emergency department. Pediatr Emerg Care 37(7):e360–e366. https://doi.org/10.1097/PEC.0000000000001619

    Article  PubMed  Google Scholar 

  82. Lin YC, Perez S, Tung C (2019) Acupuncture for pediatric pain: the trend of evidence-based research. J Tradit Complement Med 10(4):315–319. https://doi.org/10.1016/j.jtcme.2019.08.004

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Doll E, Threlkeld B, Graff D, Clemons R, Mittel O, Sowell MK, McDonald M (2019) Acupuncture in adult and pediatric headache: a narrative review. Neuropediatrics 50(6):346–352. https://doi.org/10.1055/s-0039-1695785

    Article  PubMed  Google Scholar 

  84. Gottschling S, Meyer S, Gribova I, Distler L, Berrang J, Gortner L, Graf N, Shamdeen GM (2008) Laser acupuncture in children with headache: a double-blind, randomized, bicenter, placebo-controlled trial. Pain 137(2):405–412. https://doi.org/10.1016/j.pain.2007.10.004

    Article  PubMed  Google Scholar 

  85. Lynge S, Dissing KB, Vach W, Christensen HW, Hestbaek L (2021) Effectiveness of chiropractic manipulation versus sham manipulation for recurrent headaches in children aged 7–14 years—a randomised clinical trial. Chiropr Man Therap 29(1):1. https://doi.org/10.1186/s12998-020-00360-3

    Article  PubMed  PubMed Central  Google Scholar 

  86. Alcantara J, Pankonin KJ (2010) Chiropractic care of a pediatric patient with migraine-type headaches: a case report and selective review of the literature. Explore (NY) 6(1):42–46. https://doi.org/10.1016/j.explore.2009.10.005

    Article  PubMed  Google Scholar 

  87. Roberts J, Wolfe T (2009) Chiropractic care of a 6-year-old girl with neck pain; headaches; hand, leg, and foot pain; and other nonmusculoskeletal symptoms. J Chiropr Med 8(3):131–136. https://doi.org/10.1016/j.jcm.2009.04.002

    Article  PubMed  PubMed Central  Google Scholar 

  88. Borusiak P, Biedermann H, Bosserhoff S, Opp J (2010) Lack of efficacy of manual therapy in children and adolescents with suspected cervicogenic headache: results of a prospective, randomized, placebo-controlled, and blinded trial. Headache 50(2):224–230. https://doi.org/10.1111/j.1526-4610.2009.01550.x

    Article  PubMed  Google Scholar 

  89. Jong MC, Boers I, van Wietmarschen HA, Tromp E, Busari JO, Wennekes R, Snoeck I, Bekhof J, Vlieger AM (2019) Hypnotherapy or transcendental meditation versus progressive muscle relaxation exercises in the treatment of children with primary headaches: a multi-centre, pragmatic, randomised clinical study. Eur J Pediatr 178(2):147–154. https://doi.org/10.1007/s00431-018-3270-3

    Article  CAS  PubMed  Google Scholar 

  90. Kohen DP, Zajac R (2007) Self-hypnosis training for headaches in children and adolescents. J Pediatr 150(6):635–639. https://doi.org/10.1016/j.jpeds.2007.02.014

    Article  PubMed  Google Scholar 

  91. Kohen DP (2010) Long-term follow-up of self-hypnosis training for recurrent headaches: what the children say. Int J Clin Exp Hypn 58(4):417–432. https://doi.org/10.1080/00207144.2010.499342

    Article  PubMed  Google Scholar 

  92. Rastogi RG, Arnold TL, Borrero-Mejias C, Hastriter EV, Hickman C, Karnik KT, Lewis KS, Little RD (2021) Non-pharmacologic and mindful-based approaches for pediatric headache disorders: a review. Curr Pain Headache Rep 25(12):78. https://doi.org/10.1007/s11916-021-00993-w

    Article  PubMed  Google Scholar 

  93. Anheyer D, Leach MJ, Klose P, Dobos G, Cramer H (2019) Mindfulness-based stress reduction for treating chronic headache: a systematic review and meta-analysis. Cephalalgia 39(4):544–555. https://doi.org/10.1177/0333102418781795

    Article  PubMed  Google Scholar 

  94. Sethi BB, Trivedi JK, Anand R (1981) A comparative study of relative effectiveness of biofeedback and shavasana (yoga) in tension headache. Indian J Psychiatry 23(2):109–114

    CAS  PubMed  PubMed Central  Google Scholar 

  95. Gaul C (2014) Headache: patient education as part of a multidisciplinary treatment. Are there reliable results? Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 57(8):961–966. https://doi.org/10.1007/s00103-014-2002-8

    Article  CAS  PubMed  Google Scholar 

  96. Kuburas A, Russo AF (2023) Shared and independent roles of CGRP and PACAP in migraine pathophysiology. J Headache Pain 24(1):34. https://doi.org/10.1186/s10194-023-01569-2

    Article  PubMed  PubMed Central  Google Scholar 

  97. Schulte LH, May A (2016) The migraine generator revisited: continuous scanning of the migraine cycle over 30 days and three spontaneous attacks. Brain 139(7):1987–1993. https://doi.org/10.1093/brain/aww097

    Article  PubMed  Google Scholar 

  98. Vanderpol J, Bishop B, Matharu M, Glencorse M (2015) Therapeutic effect of intranasal evaporative cooling in patients with migraine: a pilot study. J Headache Pain 16:5. https://doi.org/10.1186/1129-2377-16-5

    Article  PubMed  PubMed Central  Google Scholar 

  99. Al-Hashel JY, Abokalawa F, Toma R, Algubari A, Ahmed SF (2021) Worsening of migraine headache with fasting Ramadan. Clin Neurol Neurosurg 209:106899. https://doi.org/10.1016/j.clineuro.2021.106899

    Article  PubMed  Google Scholar 

  100. Straube A, Ruscheweyh R (2020) Migräne und der Gastrointestinaltrakt. Eine wechselseitige Beziehung. Nervenheilkunde 39:26–30. https://doi.org/10.1055/a-1037-2289

    Article  Google Scholar 

  101. Straube A, Eren O, Gaul C (2016) Wie der Nervus vagus bei Kopfschmerzen mitspielt. MMW Fortschr Med 158(6):74–76. https://doi.org/10.1007/s15006-016-8010-x

    Article  PubMed  Google Scholar 

  102. Evcili G, Utku U, Öğün MN, Özdemir G (2018) Early and long period follow-up results of low glycemic index diet for migraine prophylaxis. Agri 30(1):8–11. https://doi.org/10.5505/agri.2017.62443

    Article  PubMed  Google Scholar 

  103. Razeghi Jahromi S, Ghorbani Z, Martelletti P, Lampl C, Togha M, School of Advanced Studies of the European Headache Federation (EHF-SAS) (2019) Association of diet and headache. J Headache Pain 20(1):106. https://doi.org/10.1186/s10194-019-1057-1

    Article  PubMed  PubMed Central  Google Scholar 

  104. Macri E, Azhar Y (2022) Prevention of neurologic disease with fasting. Semin Neurol 42(5):549–557. https://doi.org/10.1055/a-1957-8449

    Article  PubMed  Google Scholar 

  105. Hu C, Fan Y, Wu S, Zou Y, Qu X (2021) Vitamin D supplementation for the treatment of migraine: a meta-analysis of randomized controlled studies. Am J Emerg Med 50:784–788. https://doi.org/10.1016/j.ajem.2021.07.062

    Article  PubMed  Google Scholar 

  106. Ernst E (1999) Homeopathic prophylaxis of headaches and migraine? A systematic review. J Pain Symptom Manage 18(5):353–357. https://doi.org/10.1016/s0885-3924(99)00095-0

    Article  CAS  PubMed  Google Scholar 

  107. Sédat J, Dib M, Mahagne MH, Lonjon M, Paquis P (2002) Stroke after chiropractic manipulation as a result of extracranial postero-inferior cerebellar artery dissection. J Manipulative Physiol Ther 25(9):588–590. https://doi.org/10.1067/mmt.2002.128955

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Kopfschmerzzentrum Frankfurt, Dalbergstr. 2a, 65929, Frankfurt, Deutschland

    Charly Gaul

  2. Klinik und Poliklinik für Kinder- und Jugendmedizin, Universitätsklinikum Dresden, Dresden, Deutschland

    Laura Zaranek

  3. Universitäts SchmerzCentrum – USC, Universitätsklinikum Dresden, Medizinische Fakultät, Technische Universität Dresden, Dresden, Deutschland

    Gudrun Goßrau

Authors
  1. Charly Gaul
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laura Zaranek
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gudrun Goßrau
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Charly Gaul.

Ethics declarations

Interessenkonflikt

C. Gaul erhielt in den letzten 3 Jahren Honorare für Vorträge und Beratung von AbbVie, Lilly, Novartis Pharma, Hormosan Pharma, Grünenthal, Sanofi-Aventis, Lundbeck, Perfood, Reckitt, Vectura Fertin Pharma, Chordate und TEVA-Ratiopharm. Er erhält Forschungsförderung durch die Deutsche Forschungsgemeinschaft (DFG). Er besitzt keine Aktien oder Anteile pharmazeutischer Unternehmen. Er ist ehrenamtlicher Generalsekretär der Deutschen Migräne- und Kopfschmerzgesellschaft (DMKG). L. Zaranek und G. Goßrau geben an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden von den Autor/-innen keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Additional information

figure qr

QR-Code scannen & Beitrag online lesen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gaul, C., Zaranek, L. & Goßrau, G. Komplementäre und ergänzende Verfahren in der Kopfschmerztherapie. Schmerz 37, 448–460 (2023). https://doi.org/10.1007/s00482-023-00738-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00482-023-00738-1

Schlüsselwörter

Keywords

Search

Navigation